ArticleJACC. Advances2025
Automated Detection of Reduced Ejection Fraction Using an ECG-Enabled Digital Stethoscope: A Large Cohort Validation.
Article in JACC. Advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to trial NCT07087613 (Deep Learning for Detection of Pulmonary Hypertension and Reduced Left Ventricular Ejection Fraction Using a Combined Digital Stethoscope and Three-lead Electrocardiogram), which is not on this map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Deep Learning for Detection of Pulmonary Hypertension and Reduced Left Ventricular Ejection Fraction Using a Combined Digital Stethoscope and Three-lead Electrocardiogram
Who cites it
12 citing papers in PubMed.
- External validation of artificial intelligence-guided electrocardiogram (AI-ECG) in detecting asymptomatic left ventricular dysfunction: A systematic review and meta-analysis.American journal of preventive cardiology · 2027Article
- From wrist to heart: clinical validation and real-world translation of wearable and portable AI-enhanced electrocardiography.European heart journal. Digital health · 2026Review
- The Digital Evolution of the Medical Black Bag: Environmental Scan With Trend Analysis and Horizon Scanning.Journal of medical Internet research · 2026Article
- Advances in the Interpretation of the Electrocardiogram by Artificial Intelligence.Diagnostics (Basel, Switzerland) · 2026Review
- Artificial intelligence across the cardiovascular diagnostic pathway: a case-based narrative review.Cardiovascular diagnosis and therapy · 2026Review
- Integrating multimodal intelligence in heart failure: AI-driven risk prediction, precision diagnosis, phenotyping, personalized treatment, and prognosis.Chinese medical journal · 2026Review
- Evaluation of the DAMSUN-HF trial: the role of an artificial intelligence stethoscope in detecting reduced ejection fraction in patients living in a low-resource region.Heart failure reviews · 2026Review
- Artificial intelligence in early heart failure detection: from algorithms to bedside integration.Frontiers in cardiovascular medicine · 2026Article
- Non-Invasive Wearable Technology to Predict Heart Failure Decompensation.Journal of clinical medicine · 2025Review
- World Heart Day 2025: Don't Miss a Beat - bridging gaps in cardiovascular health for women, children and the future.Singapore medical journal · 2025Article
- Artificial intelligence analysis of the single-lead ECG predicts long-term clinical outcomes.European heart journal. Digital health · 2025Article
- Foundation models for cardiovascular disease detection via biosignals from digital stethoscopes.NPJ cardiovascular health · 2024Article
Corrections and comments
- Erratum issued
Authors and funding
18 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAsymptomatic left ventricular systolic dysfunction (ALVSD) affects 7 million globally, leading to delayed diagnosis and treatment, high mortality, and substantial downstream health care costs. Current detection methods for ALVSD are inadequate, necessitating the development of improved diagnostic tools. Recently, electrocardiogram-based algorithms have shown promise in detecting ALVSD.
objectivesThe authors developed and validated a convolutional neural network (CNN) model using single-lead electrocardiogram and phonocardiogram inputs captured by a digital stethoscope to assess its utility in detecting individuals with actionably low ejection fractions (EF) in a large cohort of patients.
methods2,960 adults undergoing echocardiography from 4 U.S. health care networks were enrolled in this multicenter observational study. Patient data were captured using a digital stethoscope, and echocardiograms were performed within 1 week of data collection. The algorithm's performance was compared against echocardiographic EF (EF measurements, categorizing EF as normal and mildly reduced [>40%] or moderate and severely reduced [≤40%]).
resultsThe CNN model demonstrated an area under the receiver operating characteristic curve of 0.85, with a sensitivity of 77.5%, specificity of 78.3%, positive predictive value of 20.3%, and negative predictive value of 98.0%. Among those with an abnormal artificial intelligence screen but EF >40% (false positives), 25% had an EF between 41%-49% and 63% had conduction/rhythm abnormalities. Subgroup analyses indicated consistent performance across various demographics and comorbidities.
conclusionsThe CNN model, utilizing a digital stethoscope, offers a noninvasive and scalable method for early detection of individuals with EF ≤40%. This technology has the potential to facilitate early diagnosis and treatment of heart failure, thereby improving patient outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.